Literature DB >> 1839491

Comparison of the Tu elongation factors from Staphylococcus aureus and Escherichia coli: possible basis for elfamycin insensitivity.

C C Hall1, J D Watkins, N H Georgopapadakou.   

Abstract

In a previous study (C. C. Hall, J. D. Watkins, and N. H. Georgopapadakou, Antimicrob. Agents Chemother. 33:322-325, 1989), the elongation factor Tu (EF-Tu) from Staphylococcus aureus was found to be insensitive to a series of kirromycin analogs which were inhibitory to the EF-Tu from Escherichia coli. In the present study, the EF-Tu from S. aureus was partially purified and characterized. Its apparent molecular mass was approximately 41,000 Da, and the enzyme copurified with EF-Ts (molecular mass, 34,000 Da). S. aureus EF-Tu differed from its E. coli counterpart in that it bound negligible amounts of [3H]GDP, in addition to being insensitive to pulvomycin and aurodox (50% inhibitory concentrations, approximately 100 and 1,000 microM, respectively, versus 2 and 0.2 microM, respectively, for E. coli). The results are consistent with the formation of a stable EF-Tu.EF-Ts complex that affects the interaction of EF-Tu with guanine nucleotides and inhibitors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839491      PMCID: PMC245386          DOI: 10.1128/AAC.35.11.2366

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Affinity purification of elongation factors Tu and Ts.

Authors:  G R Jacobson; J P Rosenbusch
Journal:  FEBS Lett       Date:  1977-07-01       Impact factor: 4.124

2.  Elongation factor Tu and the aminoacyl-tRNA-EFTu-GTP complex.

Authors:  D L Miller; H Weissbach
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

3.  Studies on the purification and properties of factor Tu from E. coli.

Authors:  D L Miller; H Weissbach
Journal:  Arch Biochem Biophys       Date:  1970-11       Impact factor: 4.013

4.  A comparative study of the 50S ribosomal subunit and several 50S subparticles in EF-T-and EF-G-dependent activities.

Authors:  G Sander; R C Marsh; J Voigt; A Parmeggiani
Journal:  Biochemistry       Date:  1975-05-06       Impact factor: 3.162

Review 5.  Staphylococcus aureus. The persistent pathogen (second of two parts).

Authors:  J N Sheagren
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

6.  Studies on polypeptide-chain-elongation factors from an extreme thermophile, Thermus thermophilus HB8. 1. Purification and some properties of the purified factors.

Authors:  K Arai; Y Ota; N Arai; S Nakamura; C Henneke; T Oshima; Y Kaziro
Journal:  Eur J Biochem       Date:  1978-12

7.  Purification of Euglena gracilis chloroplast elongation factor Ts.

Authors:  L Fox; N Brot; H Weissbach
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

8.  Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus.

Authors:  C C Hall; J D Watkins; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

9.  Penicillin-binding proteins in a Staphylococcus aureus strain resistant to specific beta-lactam antibiotics.

Authors:  N H Georgopapadakou; S A Smith; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

10.  Kirromycin-resistant elongation factor Tu from wild-type of Lactobacillus brevis.

Authors:  W Wörner; H Wolf
Journal:  FEBS Lett       Date:  1982-09-20       Impact factor: 4.124

View more
  4 in total

1.  Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.

Authors:  Lian N Olsthoorn-Tieleman; Robert-Jan T S Palstra; Gilles P van Wezel; Mervyn J Bibb; Cornelis W A Pleij
Journal:  J Bacteriol       Date:  2007-03-02       Impact factor: 3.490

Review 2.  Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.

Authors:  Patrick Butaye; Luc A Devriese; Freddy Haesebrouck
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

3.  Differential susceptibilities of enterococcal species to elfamycin antibiotics.

Authors:  A Miele; B P Goldstein; M Bandera; C Jarvis; A Resconi; R J Williams
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

4.  Cloning and characterization of EF-Tu and EF-Ts from Pseudomonas aeruginosa.

Authors:  Stephanie O Palmer; Edna Y Rangel; Alberto E Montalvo; Alexis T Tran; Kate C Ferguson; James M Bullard
Journal:  Biomed Res Int       Date:  2013-08-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.